Targeting EGFR and ERBB3 in lung cancer patients: Clinical outcomes in a phase I trial of MM-121 in combination with erlotinib.

被引：0
|
作者：
Sequist, Lecia V.
Modiano, Manuel R.
Rixe, Olivier
Jackman, David Michael
Andreas, Karen
Pearlberg, Joseph
Moyo, Victor M.
Harb, Wael A.
机构：
[1] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[2] Arizona Clin Res Ctr, Tucson, AZ USA
[3] Univ Cincinnati, Cincinnati, OH USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Merrimack Pharmaceut, Cambridge, MA USA
[6] Sanofi Oncol, Cambridge, MB, Canada
[7] Horizon Oncol Ctr, Lafayette, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7556
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A randomized phase 2 trial of MM-121, a fully human monoclonal antibody targeting ErbB3, in combination with erlotinib in EGFR wild-type NSCLC patients.
    Sequist, Lecia V.
    Lopez-Chavez, Ariel
    Doebele, Robert Charles
    Gray, Jhanelle Elaine
    Harb, Wael A.
    Modiano, Manuel R.
    Jackman, David Michael
    Baggstrom, Maria Quintos
    Atmaca, Akin
    Felip, Enriqueta
    Provencio, Mariano
    Cobo, Manuel
    Kripas, Christopher J.
    MacBeath, Gavin
    Czibere, Akos Gabor
    Cho, Byoung Chul
    Park, Keunchil
    Shepherd, Frances A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] A phase I/II trial of MM-121 in combination with erlotinib in patients (pts) with non-small cell lung cancer (NSCLC).
    Sequist, L. V.
    Harb, W. A.
    Modiano, M.
    Jackman, D. M.
    Wong, K.
    Engelman, J. A.
    Nering, R.
    Onsum, M.
    Moyo, V. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] Phase I dose escalation study of MM-121, a fully human monoclonal antibody to ErbB3, in patients with advanced solid tumors
    Denlinger, Crystal S.
    Keedy, Vicki L.
    Cleary, James M.
    Kubasek, William
    Onsum, Matthew
    Moulis, Sharon
    Garcia, Gabriela
    Schoeberl, Birgit
    MacBeath, Gavin
    Nering, Rachel
    Murray, James
    Moyo, Victor
    Wong, Kwok-Kin
    Shapiro, Geoffrey
    CANCER RESEARCH, 2011, 71
  • [4] A phase I study of MM-121 (a fully human monoclonal antibody targeting the epidermal growth factor receptor family member ErbB3) in combination with cetuximah and irinotecan in patients with advanced cancers
    Cleary, James M.
    McRee, Autumn Jackson
    O'Nei, Bert H.
    Sharma, Sunil
    Pearlberg, Joseph
    Manoli, Sara
    Kubasek, William Lloyd
    Korn, W. Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer
    Shuiliang Wang
    Jingcao Huang
    Hui Lyu
    Bo Cai
    Xiaoping Yang
    Fang Li
    Jianming Tan
    Susan M Edgerton
    Ann D Thor
    Choon-Kee Lee
    Bolin Liu
    Breast Cancer Research, 15
  • [6] Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer
    Wang, Shuiliang
    Huang, Jingcao
    Lyu, Hui
    Cai, Bo
    Yang, Xiaoping
    Li, Fang
    Tan, Jianming
    Edgerton, Susan M.
    Thor, Ann D.
    Lee, Choon-Kee
    Liu, Bolin
    BREAST CANCER RESEARCH, 2013, 15 (05):
  • [7] In-vitro studies of MM-121/SAR 256212, an anti-ErbB-3 antibody, in combination with erlotinib in EGFR-wild-type NSCLC.
    Wainszelbaum, Marisa J.
    Sevecka, Mark S.
    Burenkova, Olga
    Garcia, Gabriela
    Kubasek, William
    MacBeath, Gavin
    CANCER RESEARCH, 2013, 73 (08)
  • [8] A PHASE 1 STUDY OF THE ANTI-ERBB3 ANTIBODY MM-121 IN COMBINATION WITH WEEKLY PACLITAXEL IN PATIENTS WITH ADVANCED GYNECOLOGICAL AND BREAST CANCERS
    Liu, J.
    Patel, R.
    Kato, G.
    Matulonis, U.
    Moyo, V.
    Riahi, K.
    Pearlberg, J.
    Czibere, A.
    Isakoff, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 321 - 321
  • [9] A phase I study of MM-121 in combination with multiple anticancer therapies in patients with advanced solid tumors.
    Arnedos, Monica
    Denlinger, Crystal Shereen
    Harb, Wael A.
    Rixe, Olivier
    Morris, John Charles
    Dy, Grace K.
    Adjei, Alex A.
    Pearlberg, Joseph
    Follows, Sarah
    Czibere, Akos Gabor
    Soria, Jean-Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [10] In vivo effect of combination therapy: An anti ErbB3 antibody, MM121, plus selected cancer therapies
    Burenkova, Olga
    Fulgham, Aaron
    Kalra, Ashish
    Onsum, Matt
    Linggi, Bryan
    Schoeberl, Birgit
    West, Kip
    Leszczyniecka, Magdalena
    Paragas, Violette
    Nie, Lin
    Xu, Lihui
    Grantcharova, Viara
    Xiao, Dongmei
    Latimer, Howard
    Moulis, Sharon
    Alves, Washington
    Varghese, Jose
    Wallace, Matt
    Bukhalid, Raghida
    Garcia, Gabriela
    Kubasek, Bill
    Slichenmyer, Bill
    Feldhaus, Michael
    Nielsen, Ulrik
    CANCER RESEARCH, 2009, 69
12345